Acorda Therapeutics
ACOR
#10025
Rank
NZ$1.37 M
Marketcap
$1.11
Share price
0.00%
Change (1 day)
-95.69%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -NZ$0.44 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are NZ$0.11 Billion. In 2023 the company made an earning of -NZ$0.45 Billion a decrease over its 2022 earnings that were of -NZ$8.95 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.44 Billion-2.45%
2023 -NZ$0.45 Billion4848.63%
2022 -NZ$8.95 Million-93.25%
2021 -NZ$0.14 Billion2.52%
2020 -NZ$0.13 Billion-69.45%
2019 -NZ$0.43 Billion-700.62%
2018 NZ$70.44 M-118.02%
2017 -NZ$0.4 Billion805.99%
2016 -NZ$43.16 Million-173.88%
2015 NZ$58.4 M-6.58%
2014 NZ$62.52 M20.19%
2013 NZ$52.02 M18.7%
2012 NZ$43.82 M-26.54%
2011 NZ$59.65 M
2009 -NZ$0.14 Billion10.65%
2008 -NZ$0.13 Billion86.17%
2007 -NZ$66.13 Million68.1%
2006 -NZ$39.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$35.96 M-107.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.50 B-209.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.15 Billion-68.58%๐Ÿ‡ฉ๐Ÿ‡ช Germany
NZ$0.10 B-122.89%๐Ÿ‡บ๐Ÿ‡ธ USA